Glass House Brands (GLAS) Equity Income (2022 - 2025)
Glass House Brands (GLAS) posted quarterly Equity Income of -$44000.0 for Q2 2025, down 146.81% year-over-year from $94000.0 in Q2 2024, and up 2.22% quarter-over-quarter from -$45000.0 in Q3 2024.
Glass House Brands (GLAS) Equity Income (2022 - 2025) Analysis & Trends
Glass House Brands (GLAS) has reported Equity Income for 4 consecutive years, with -$44000.0 the latest figure, recorded in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -500,000.00 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 3.38 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 835.49 Mn | 816.93 Mn | 15.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -44,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | 94,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Sep 30, 2023 | -91,248.00 |
| Jun 30, 2023 | -35.81 Bn |
| Mar 31, 2023 | 2.26 Mn |
| Sep 30, 2022 | 871,329.00 |
| Jun 30, 2022 | 73.00 Bn |